Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Chuangye He

Showing results (21-30 of 50) with videos related to

Pageof 5
Sort By:
Frontiers in Pediatrics|May 31, 2022
Electric Insulating Irrigations Mitigates Esophageal Injury Caused by Button Battery IngestionWenyuan Jia, Guanghui Xu, Jiangang Xie, et al.
Liver International : Official Journal of the International Association for the Study of the Liver|August 4, 2015
Transjugular intrahepatic portosystemic shunt for portal vein thrombosis with variceal bleeding in liver cirrhosis: outcomes and predictors in a prospective cohort studyXingshun Qi, Chuangye He, Wengang Guo, et al.
Medical Science Monitor : International Medical Journal of Experimental and Clinical Research|August 1, 2012
Transjugular intrahepatic portosystemic shunt may be superior to conservative therapy for variceal rebleeding in cirrhotic patients with non-tumoral portal vein thrombosis: a hypothesisXingshun Qi, Guohong Han, Chuangye He, et al.
Radiology|November 13, 2012
Percutaneous recanalization for Budd-Chiari syndrome: an 11-year retrospective study on patency and survival in 177 Chinese patients from a single centerGuohong Han, Xingshun Qi, Wei Zhang, et al.
Cardiovascular and Interventional Radiology|October 24, 2014
Percutaneous transhepatic biliary metal stent for malignant hilar obstruction: results and predictive factors for efficacy in 159 patients from a single centerMingwu Li, Ming Bai, Xingshun Qi, et al.
Journal of Hepatology|October 12, 2010
Transjugular intrahepatic portosystemic shunt for portal vein thrombosis with symptomatic portal hypertension in liver cirrhosisGuohong Han, Xingshun Qi, Chuangye He, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|February 5, 2014
EASL- and mRECIST-evaluated responses to combination therapy of sorafenib with transarterial chemoembolization predict survival in patients with hepatocellular carcinomaLei Liu, Weijuan Wang, Hui Chen, et al.
Journal of Pediatric Gastroenterology and Nutrition|September 19, 2015
Transjugular Intrahepatic Portosystemic Shunt for Extrahepatic Portal Venous Obstruction in ChildrenYong Lv, Chuangye He, Wengang Guo, et al.
Journal of Gastroenterology and Hepatology|December 7, 2011
Prevalence of the JAK2V617F mutation in Chinese patients with Budd-Chiari syndrome and portal vein thrombosis: a prospective studyXingshun Qi, Cheng Zhang, Guohong Han, et al.
Academic Radiology|May 6, 2025
Covered TIPS Created with Viatorr Versus Fluency Stent-Grafts for the Refractory Ascites in Patients with Cirrhosis: An Observational StudyZengqiang Wang, Jun Wang, Junjun Ye, et al.
Pageof 5

Showing results (21-30 of 50) with videos related to

Sort By:
Pageof 5
Frontiers in Pediatrics|May 31, 2022
Electric Insulating Irrigations Mitigates Esophageal Injury Caused by Button Battery IngestionWenyuan Jia, Guanghui Xu, Jiangang Xie, et al.
Liver International : Official Journal of the International Association for the Study of the Liver|August 4, 2015
Transjugular intrahepatic portosystemic shunt for portal vein thrombosis with variceal bleeding in liver cirrhosis: outcomes and predictors in a prospective cohort studyXingshun Qi, Chuangye He, Wengang Guo, et al.
Medical Science Monitor : International Medical Journal of Experimental and Clinical Research|August 1, 2012
Transjugular intrahepatic portosystemic shunt may be superior to conservative therapy for variceal rebleeding in cirrhotic patients with non-tumoral portal vein thrombosis: a hypothesisXingshun Qi, Guohong Han, Chuangye He, et al.
Radiology|November 13, 2012
Percutaneous recanalization for Budd-Chiari syndrome: an 11-year retrospective study on patency and survival in 177 Chinese patients from a single centerGuohong Han, Xingshun Qi, Wei Zhang, et al.
Cardiovascular and Interventional Radiology|October 24, 2014
Percutaneous transhepatic biliary metal stent for malignant hilar obstruction: results and predictive factors for efficacy in 159 patients from a single centerMingwu Li, Ming Bai, Xingshun Qi, et al.
Journal of Hepatology|October 12, 2010
Transjugular intrahepatic portosystemic shunt for portal vein thrombosis with symptomatic portal hypertension in liver cirrhosisGuohong Han, Xingshun Qi, Chuangye He, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|February 5, 2014
EASL- and mRECIST-evaluated responses to combination therapy of sorafenib with transarterial chemoembolization predict survival in patients with hepatocellular carcinomaLei Liu, Weijuan Wang, Hui Chen, et al.
Journal of Pediatric Gastroenterology and Nutrition|September 19, 2015
Transjugular Intrahepatic Portosystemic Shunt for Extrahepatic Portal Venous Obstruction in ChildrenYong Lv, Chuangye He, Wengang Guo, et al.
Journal of Gastroenterology and Hepatology|December 7, 2011
Prevalence of the JAK2V617F mutation in Chinese patients with Budd-Chiari syndrome and portal vein thrombosis: a prospective studyXingshun Qi, Cheng Zhang, Guohong Han, et al.
Academic Radiology|May 6, 2025
Covered TIPS Created with Viatorr Versus Fluency Stent-Grafts for the Refractory Ascites in Patients with Cirrhosis: An Observational StudyZengqiang Wang, Jun Wang, Junjun Ye, et al.
Pageof 5